JULIAN C. BAKER - Corporate Board Profile

ACADIA PHARMACEUTICALS INC

Filing Date	Source Excerpt
2018-04-30	Julian C. Baker(4) Fees Earned or Paid in Cash includes Annual Retainer of $50,000, Additional Retainer for Compensation Member (non-Chair) of $10,000. Option Awards includes the fair value of 15,000 stock options granted June 13, 2017 with an exercise price of $27.25. As of December 31, 2017, an aggregate of 42,500 stock options that had been granted to Mr. Baker were outstanding.
2020-04-29	Julian C. Baker, age 53, has served as a director of our company since December 2015... The following table shows, for the fiscal year ended December 31, 2019, certain information with respect to the compensation of all non-employee directors of the Company during 2019... Julian C. Baker: Fees Earned or Paid in Cash $60,000, Option Awards $214,959, Total $274,959.
2021-04-30	Julian C. Baker 54 Director ... "Fees Earned or Paid in Cash" represents an annual retainer as a Board member of $50,000 and an additional retainer as a Compensation Committee member (non-chair) of $10,000. "Option Awards" includes the fair value of 5,579 stock options granted June 23, 2020 with an exercise price of $52.73. "Stock Awards" includes the fair value of 3,059 restricted stock units granted June 23, 2020. As of December 31, 2020, an aggregate of 78,079 stock options and 3,059 restricted stock units that had been granted to Mr. Baker were outstanding.
2022-04-29	Julian C. Baker 55 Director... The following table shows, for the fiscal year ended December 31, 2021, certain information with respect to the compensation of all non-employee directors of the Company during 2021... Julian C. Baker Fees Earned or Paid in Cash $60,000, Option Awards $167,690, Stock Awards $159,008, Total $386,698.
2023-05-01	Julian C. Baker has served as a director of the Company since December 2015. Mr. Baker is a Managing Member of Baker Brothers Investments. Mr. Baker founded Baker Bros., together with his brother, Felix Baker, Ph.D., in 2000. Prior to founding Baker Bros., Mr. Baker was a portfolio manager at Tisch Financial Management from 1994 to 1999. Previously, Mr. Baker was employed from 1988 to 1993 by the private equity investment arm of Credit Suisse First Boston Corporation. Mr. Baker currently serves on the boards of directors of Incyte Corporation, Prelude Therapeutics, Inc., Everyone Medicines, Inc. and Alumis Inc. During the past five years, Mr. Baker has served on the boards of directors of Genomic Health, Inc. and Idera Pharmaceuticals, Inc. Mr. Baker holds an A.B. from Harvard University. The NCG Committee believes that Mr. Baker is qualified to serve as a member of our board of directors based on his extensive financial industry experience focused on life science companies. The following table shows, for the fiscal year ended December 31, 2022, certain information with respect to the compensation of all non-employee directors of the Company during 2022. Mr. Davis, our Chief Executive Officer, does not receive additional compensation for his services as a director. Julian C. Baker Fees Earned or Paid in Cash $60,000 Option Awards $156,098 Stock Awards $156,245 All Other Compensation $0 Total $372,343
2024-04-26	Julian C. Baker has served as a director of the Company since December 2015. Mr. Baker is a Managing Member of Baker Bros. Advisors LP ("Baker Bros."), a registered investment adviser focused on long-term investments in life-sciences companies. Mr. Baker founded Baker Bros., together with his brother, Felix Baker, Ph.D., in 2000. Prior to founding Baker Bros., Mr. Baker was a portfolio manager at Tisch Financial Management from 1994 to 1999. Previously, Mr. Baker was employed from 1988 to 1993 by the private equity investment arm of Credit Suisse First Boston Corporation. Mr. Baker currently serves on the boards of directors of Incyte Corporation, Prelude Therapeutics Incorporated and Madrigal Pharmaceuticals, Inc., each public companies. Mr. Baker also serves on the boards of directors of Everyone Medicines, Inc. and Alumis Inc., each privately held companies. During the past five years, Mr. Baker has served on the boards of directors of Genomic Health, Inc. and Idera Pharmaceuticals, Inc. Mr. Baker holds an A.B. from Harvard University. The NCG Committee believes that Mr. Baker is qualified to serve as a member of our board of directors based on his extensive financial industry experience focused on life science companies. The Board has an Audit Committee, a Compensation Committee, a Nominating and Corporate Governance Committee and a Scientific Advisory Committee. The following table provides membership and meeting information for 2023: Julian C. Baker: Audit Committee. The following table shows, for the fiscal year ended December 31, 2023, certain information with respect to the compensation of all non-employee directors of the Company during 2023. Julian C. Baker: Fees Earned or Paid in Cash $60,000, Option Awards $158,770, Stock Awards $158,983, Total $377,752.

INCYTE CORP

Filing Date	Source Excerpt
2017-04-17	Julian C. Baker is a Managing Partner of Baker Brothers Investments, which he and his brother, Felix Baker, Ph.D., founded in 2000. Baker Brothers Investments is a fund management company focused on long-term investments in publicly traded life sciences companies. Mr. Baker's career as a fund manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch family. Previously, Mr. Baker was employed from 1988 to 1993 by the private equity investment arm of Credit Suisse First Boston Corporation. Mr. Baker is also a director of Acadia Pharmaceuticals, Inc., Genomic Health, Inc. and Idera Pharmaceuticals, Inc., and was a director of Trimeris, Inc. from April 2004 until November 2011.
2018-03-14	Julian C. BakerLead Independent Director Managing Partner Baker Brothers Investments Director since 2001 Age 51 Committees Compensation Finance Nominating & Corporate Governance (Chair) Mr. Baker is a Managing Partner of Baker Brothers Investments, which he and his brother, Felix Baker, Ph.D., founded in 2000.
2019-03-21	Mr. Baker is a Managing Partner of Baker Brothers Investments, which he and his brother, Felix Baker, Ph.D., founded in 2000. Baker Brothers Investments is an investment advisor focused on long term investments in life sciences companies.
2020-04-20	Julian C. Baker LEAD INDEPENDENT DIRECTOR Age: 53 COMMITTEES: Compensation Nominating and Corporate Governance (Chair) DIRECTOR SINCE: 2001 Mr. Baker is a Managing Partner of Baker Brothers Investments, which he and his brother, Felix Baker, Ph.D., founded in 2000.
2021-04-16	Mr. Baker is a Managing Member of Baker Bros. Advisors LP, which he and his brother, Felix Baker, Ph.D., founded in 2000. Baker Bros. Advisors LP is a biotechnology-focused investment advisor to fund partnerships whose investors are primarily endowments and foundations. Mr. Baker's career as a fund manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch family.
2022-04-29	Mr. Baker is a Managing Member of Baker Bros. Advisors LP, which he and his brother, Felix Baker, Ph.D., founded in 2000. Baker Bros. Advisors LP is a biotechnology-focused investment advisor to fund partnerships whose investors are primarily endowments and foundations. Mr. Baker’s career as a fund manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch family. Previously, Mr. Baker was employed from 1988 to 1993 by the private equity investment arm of Credit Suisse First Boston Corporation. The Board has concluded that Julian C. Baker should serve on the Board because he is an experienced investor in many life sciences companies. He brings to the Board significant strategic and financial expertise and extensive knowledge of the life sciences and biopharmaceuticals industries as a result of his investments in and service as a director of other publicly and privately held life sciences companies. Other Public Company Boards: Current ACADIA Pharmaceuticals Inc. Prelude Therapeutics Incorporated Past 5 Years Genomic Health, Inc. (2001-2019) Idera Pharmaceuticals, Inc. (2014-2018)
2023-04-28	Julian C. Baker—Lead Independent Director, Managing Partner, Baker Brothers Investments, Age: 56, Director Since: 2001, Committees: Nominating and Corporate Governance (Chair), Compensation, 2022 Director Compensation Table: Total $495,468
2024-04-29	Julian C. Baker—Lead Independent Director Managing Partner Baker Brothers Investments Age: 57 COMMITTEES: Nominating and Corporate Governance (Chair), Compensation DIRECTOR SINCE: 2001